Evidence map›Paper›PMID 39878370›Full record

ArticleEuropean journal of neurology2025

Retrospective analysis of 80 patients diagnosed with reversible cerebral vasoconstriction syndrome in the Helsinki Metropolitan Area.

Maria Girfanova, Nicolas Martinez-Majander, Laura Mannismäki, Gerli Sibolt, Marjaana Tiainen, Sami Curtze

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European journal of neurology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Maria GirfanovaNeurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0009-0006-9958-0480
Nicolas Martinez-MajanderNeurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0001-8489-7051
Laura MannismäkiNeurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Gerli SiboltNeurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Marjaana TiainenNeurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Sami CurtzeNeurology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.ORCID 0000-0003-1545-8500

Funding

Maire Taposen SäätiöNeurocenter of Helsinki University HospitalThe Finnish Innovation Fund Sitra 464707
6 · The paper itself

Abstract

background and purposeUp to 80% of patients diagnosed with reversible cerebral vasoconstriction syndrome (RCVS) experience complications such as ischaemic stroke, intracerebral or subarachnoid haemorrhage or posterior reversible encephalopathy syndrome. The aim was to evaluate the incidence of complications in patients diagnosed with RCVS in our clinic. PATIENTS AND

methodsAll adult patients (age >16 years) diagnosed with RCVS at the Helsinki University Central Hospital during the period between 1 January 2016 and 31 December 2022 were retrospectively identified. Medical and follow-up data were collected from medical records.

resultsEighty patients diagnosed with RCVS were identified, of whom four patients had parenchymal lesions such as ischaemic stroke, intracerebral haemorrhage, posterior cerebral encephalopathy syndrome, subarachnoid haemorrhage or combinations thereof.

conclusionThe complication rate of RCVS is lower than in previously published cohorts. This may be related to better and earlier diagnostics and earlier withdrawal of possible triggers.

Indexed as

Posterior Leukoencephalopathy SyndromeVasospasm, IntracranialAdultAgedAged, 80 and overCerebral HemorrhageFemaleFinlandHumansMaleMiddle AgedRetrospective StudiesSubarachnoid HemorrhageSyndromeRCVSreversible cerebral vasoconstriction syndromestrokesubarachnoid haemorrhagevasoconstriction haemorrhagic stroke

Identifiers

PMID39878370
PMCPMC11775919

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.